loadpatents
name:-0.0088911056518555
name:-0.0092661380767822
name:-0.0029928684234619
Uy; Johnny Patent Filings

Uy; Johnny

Patent Applications and Registrations

Patent applications and USPTO patent grants for Uy; Johnny.The latest application filed is for "modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator".

Company Profile
15.24.25
  • Uy; Johnny - San Diego CA
  • Uy; Johnny - Boston MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Modulator Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods Of Treatment, And Process For Making The Modulator
App 20220306606 - Alcacio; Timothy ;   et al.
2022-09-29
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
Grant 11,453,655 - Abela , et al. September 27, 2
2022-09-27
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 11,426,407 - Miller , et al. August 30, 2
2022-08-30
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators
App 20220106331 - Clemens; Jeremy J. ;   et al.
2022-04-07
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
Grant 11,186,566 - Alcacio , et al. November 30, 2
2021-11-30
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
Grant 11,066,417 - Clemens , et al. July 20, 2
2021-07-20
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20210052584 - Miller; Mark Thomas ;   et al.
2021-02-25
Modulator Of The Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods Of Treatment, And Process For Making The Modulator
App 20210047295 - Abela; Alexander Russell ;   et al.
2021-02-18
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
Grant 10,793,547 - Abela , et al. October 6, 2
2020-10-06
Modulator Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods Of Treatment, And Process
App 20200283405 - Alcacio; Timothy ;   et al.
2020-09-10
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 10,758,534 - Miller , et al. Sep
2020-09-01
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 10,738,030 - Bear , et al. A
2020-08-11
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
Grant 10,570,115 - Alcacio , et al. Feb
2020-02-25
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20190269683 - Miller; Mark Thomas ;   et al.
2019-09-05
Chroman-spirocyclic piperidine amides as modulators of ion channels
Grant 10,385,070 - Hadida-Ruah , et al. A
2019-08-20
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Proces
App 20190248809 - Clemens; Jeremy J. ;   et al.
2019-08-15
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 10,258,624 - Miller , et al.
2019-04-16
Fused piperidine amides as modulators of ion channels
Grant 10,233,191 - Deninno , et al.
2019-03-19
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20190055220 - Bear; Brian ;   et al.
2019-02-21
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20180185364 - Miller; Mark Thomas ;   et al.
2018-07-05
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulator
App 20180162839 - Abela; Alexander Russell ;   et al.
2018-06-14
Modulator of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulator
App 20180093969 - Alcacio; Timothy ;   et al.
2018-04-05
Modulators of cystic fibrosis transmembrane conductance regulator
Grant 9,782,408 - Miller , et al. October 10, 2
2017-10-10
Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator
App 20170196862 - Miller; Mark Thomas ;   et al.
2017-07-13
Pyran-spirocyclic piperidine amides as modulators of ion channels
Grant 9,403,839 - Hadida-Ruah , et al. August 2, 2
2016-08-02
Benzoxazines as modulators of ion channels
Grant 9,365,588 - Hadida-Ruah , et al. June 14, 2
2016-06-14
Fused Piperidine Amides as Modulators of Ion Channels
App 20160159815 - DENINNO; Michael Paul ;   et al.
2016-06-09
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
App 20160095858 - Miller; Mark Thomas ;   et al.
2016-04-07
Quaternary ammonium compounds useful as muscarinic receptor antagonists
Grant 9,216,971 - Husfeld , et al. December 22, 2
2015-12-22
Pyran-Spirocyclic Piperidine Amides as Modulators of Ion Channels
App 20150005304 - Hadida-Ruah; Sara Sabina ;   et al.
2015-01-01
Quaternary Ammonium Compounds Useful As Muscarinic Receptor Antagonists
App 20140329857 - Husfeld; Craig ;   et al.
2014-11-06
Benzoxazines As Modulators Of Ion Channels
App 20140309220 - Hadida-Ruah; Sara Sabina ;   et al.
2014-10-16
Quaternary ammonium compounds useful as muscarinic receptor antagonists
Grant 8,815,907 - Husfeld , et al. August 26, 2
2014-08-26
Quaternary Ammonium Compounds Useful As Muscarinic Receptor Antagonists
App 20130281489 - Husfeld; Craig ;   et al.
2013-10-24
Quaternary ammonium compounds useful as muscarinic receptor antagonists
Grant 8,492,407 - Husfeld , et al. July 23, 2
2013-07-23
Chroman-spirocyclic Piperidine Amides As Modulators Of Ion Channels
App 20120245136 - HADIDA-RUAH; Sara Sabina ;   et al.
2012-09-27
Quaternary Ammonium Compounds Useful As Muscarinic Receptor Antagonists
App 20120232053 - Husfeld; Craig ;   et al.
2012-09-13
Quaternary ammonium compounds useful as muscarinic receptor antagonists
Grant 8,202,891 - Husfeld , et al. June 19, 2
2012-06-19
Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators
Grant 8,158,647 - Blaney , et al. April 17, 2
2012-04-17
Substituted Pyrrolopyridines And Pyrazolopyridines As Kinase Modulators
App 20090005356 - Blaney; Jeffrey M. ;   et al.
2009-01-01
Quaternary ammonium compounds useful as muscarinic receptor antagonists
App 20080269190 - Husfeld; Craig ;   et al.
2008-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed